Drugs Targeting B-Cells in Autoimmune Diseases (Milestones in Drug Therapy). Dieser Artikel ist nicht verfügbar.
Sprache: Englisch
Verlag: Springer, 2013
- Hardcover
- Neu

Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes KönigreichRia Christie Collections
Verkäufer:in bei ZVAB seit 25. März 2015
Zustand: Neu
EUR 187,65
Artikelbeschreibung des Verkäufers
In English.
Bestandsnummer des Verkäufers ria9783034807050_new
- Titel
- Drugs Targeting B-Cells in Autoimmune Diseases (Milestones in Drug Therapy)
- Verlag
- Springer
- Erscheinungsjahr
- 2013
- Zustand
- New
- Einband
- Hardcover
- Sprache
- Englisch
- ISBN-10
- 3034807058
- ISBN-13
- 9783034807050
- Artikelgewicht
- 727 Gramm
- Serie
- Buch 12 von 16: Milestones in Drug Therapy
This book provides a detailed overview of B-cell directed therapies in patients with rheumatic and systemic autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, Sjögren syndrome, ANCA-associated vasculitis and cryoglobulinemia. Organ-specific autoimmune diseases are discussed with respect to the use of B-cell directed therapies in neurological autoimmune diseases and autoimmune cytopenias. Situations in which B-cell targeted therapy may be indicated are identified, thereby offering comprehensive support for therapeutic decisions on the basis of the latest published evidence. The book also offers a valuable reference tool for rheumatologists, internists, nephrologists, immunologists, and all specialists involved in the multidisciplinary care of patients with rheumatic and systemic autoimmune diseases.
„Inhaltsangabe“ gehört möglicherweise zu einer anderen Auflage dieses Titels.
Von der hinteren Coverseite
This book provides a detailed overview of B-cell directed therapies in patients with rheumatic and systemic autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, Sjögren syndrome, ANCA-associated vasculitis and cryoglobulinemia. Organ-specific autoimmune diseases are discussed with respect to the use of B-cell directed therapies in neurological autoimmune diseases and autoimmune cytopenias. Situations in which B-cell targeted therapy may be indicated are identified, thereby offering comprehensive support for therapeutic decisions on the basis of the latest published evidence. The book also offers a valuable reference tool for rheumatologists, internists, nephrologists, immunologists, and all specialists involved in the multidisciplinary care of patients with rheumatic and systemic autoimmune diseases.
„Über diesen Titel“ gehört möglicherweise zu einer anderen Auflage dieses Titels.